L. Todros

952 total citations
23 papers, 688 citations indexed

About

L. Todros is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, L. Todros has authored 23 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 12 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in L. Todros's work include Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Diseases and Immunity (5 papers). L. Todros is often cited by papers focused on Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Diseases and Immunity (5 papers). L. Todros collaborates with scholars based in Italy, United Kingdom and Egypt. L. Todros's co-authors include M. Rizzetto, Carlo Alessandria, W. Debernardi‐Venon, Alfredo Marzano, Anna Morgando, Silvia Martini, F. Balzola, A. Ottobrelli, M. Torrani Cerenzia and R Galletti and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

L. Todros

22 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Todros Italy 12 485 366 274 125 98 23 688
Alberto Ferrarese Italy 18 624 1.3× 539 1.5× 310 1.1× 31 0.2× 20 0.2× 77 852
G Marenco Italy 9 356 0.7× 333 0.9× 299 1.1× 17 0.1× 14 0.1× 21 663
Anna Hüsing‐Kabar Germany 11 254 0.5× 174 0.5× 197 0.7× 68 0.5× 17 0.2× 23 448
Thomas Shaw‐Stiffel United States 11 383 0.8× 278 0.8× 255 0.9× 67 0.5× 13 0.1× 21 633
J. M. Langrehr Germany 18 286 0.6× 139 0.4× 433 1.6× 62 0.5× 32 0.3× 53 691
Paz Valer Spain 4 383 0.8× 329 0.9× 213 0.8× 19 0.2× 10 0.1× 7 517
J. Visa Spain 17 613 1.3× 194 0.5× 837 3.1× 14 0.1× 24 0.2× 50 955
Caroline Jézequel France 14 275 0.6× 199 0.5× 221 0.8× 59 0.5× 15 0.2× 32 532
Felix Gundling Germany 16 211 0.4× 233 0.6× 296 1.1× 34 0.3× 7 0.1× 78 658
Jason Soden United States 10 44 0.1× 63 0.2× 433 1.6× 432 3.5× 96 1.0× 21 750

Countries citing papers authored by L. Todros

Since Specialization
Citations

This map shows the geographic impact of L. Todros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Todros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Todros more than expected).

Fields of papers citing papers by L. Todros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Todros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Todros. The network helps show where L. Todros may publish in the future.

Co-authorship network of co-authors of L. Todros

This figure shows the co-authorship network connecting the top 25 collaborators of L. Todros. A scholar is included among the top collaborators of L. Todros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Todros. L. Todros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alessandria, Carlo, A. Ottobrelli, W. Debernardi‐Venon, et al.. (2007). Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study. Journal of Hepatology. 47(4). 499–505. 220 indexed citations
2.
Alessandria, Carlo, W. Debernardi‐Venon, L. Todros, M. Rizzetto, & Alfredo Marzano. (2007). [216] MIDODRINE IN THE PREVENTION OF HEPATORENAL SYNDROME TYPE 2 RECURRENCE: A CASE-CONTROL STUDY. Journal of Hepatology. 46. S89–S90. 1 indexed citations
3.
Saracco, Giorgio Maria, Chiara Giordanino, R Navone, et al.. (2006). Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension. Gastrointestinal Endoscopy. 65(2). 345–347. 44 indexed citations
4.
Leone, Nicola, M. Baronio, L. Todros, et al.. (2005). Hepatic involvement in larva migrans of Toxocara canis: Report of a case with pathological and radiological findings. Digestive and Liver Disease. 38(7). 511–514. 15 indexed citations
5.
Venon, W. Debernardi, M. Baronio, Nicola Leone, et al.. (2003). Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study. Journal of Hepatology. 38(4). 455–460. 16 indexed citations
6.
Sansoè, G., Giulio Mengozzi, L. Todros, et al.. (2003). Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. Journal of Hepatology. 40(3). 417–423. 11 indexed citations
7.
Sansoè, G., Giulio Mengozzi, Antonina Smedile, et al.. (2002). Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. The American Journal of Gastroenterology. 97(9). 2383–2390. 5 indexed citations
8.
Debernardi‐Venon, W., C. Barletti, Carlo Alessandria, et al.. (2002). Efficacy of Irbesartan, a Receptor Selective Antagonist of Angiotensin II, in Reducing Portal Hypertension. Digestive Diseases and Sciences. 47(2). 401–404. 17 indexed citations
9.
Venon, W. Debernardi, M. Baronio, C. Barletti, et al.. (2001). Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study. Digestive and Liver Disease. 33. A22–A22. 4 indexed citations
10.
Almasio, Piero Luigi, Annarosa Floreani, M. Chiaramonte, et al.. (2000). Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. Alimentary Pharmacology & Therapeutics. 14(12). 1645–1652. 43 indexed citations
11.
Angelis, Claudio De, P. Carucci, Maurizio Fadda, et al.. (2000). 4532 Clinical application of endoscopic ultrasound in portal hypertension: eus can predict variceal recurrence in endoscopically treated patients.. Gastrointestinal Endoscopy. 51(4). AB160–AB160. 1 indexed citations
12.
Morgando, Anna, Antonio Ponzetto, Rinaldo Pellicano, et al.. (2000). Long term follow-up after H.pylori eradication: Results of a prospective study. Gastroenterology. 118(4). A499–A499. 1 indexed citations
13.
Todros, L., et al.. (2000). Lymphocytic gastritis and protein-losing gastropathy. Digestive and Liver Disease. 32(5). 422–425. 6 indexed citations
14.
Angelis, Claudio De, P. Carucci, Maurizio Fadda, et al.. (2000). 4756 Eus can supply information of clinical usefulness and prognostic value in evaluating patients with portal hypertension (ph).. Gastrointestinal Endoscopy. 51(4). AB223–AB223.
15.
Finocchiaro, Concetta, R Galletti, Giuseppe M. Rovera, et al.. (1997). Percutaneous endoscopic gastrostomy: A long-term follow-up. Nutrition. 13(6). 520–523. 112 indexed citations
16.
Costa, Cristina, Sergio Baldi, V. Modena, et al.. (1995). Primary biliary cirrhosis: lung involvement. Liver International. 15(4). 196–201. 12 indexed citations
17.
Todros, L., Giorgio Maria Saracco, Marilena Durazzo, et al.. (1995). Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology. 22(5). 1374–1378. 62 indexed citations
18.
19.
Galletti, R, et al.. (1993). [Percutaneous endoscopic gastrostomy].. PubMed. 39(1). 23–7. 29 indexed citations
20.
Todros, L., Giovanni Antonio Touscoz, N D'Urso, et al.. (1991). Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Journal of Hepatology. 13(1). 128–131. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Ferrarese Breakdown of academic impact, for papers by G Marenco Breakdown of academic impact, for papers by Anna Hüsing‐Kabar Breakdown of academic impact, for papers by Thomas Shaw‐Stiffel Breakdown of academic impact, for papers by J. M. Langrehr Breakdown of academic impact, for papers by Paz Valer Breakdown of academic impact, for papers by J. Visa Breakdown of academic impact, for papers by Caroline Jézequel Breakdown of academic impact, for papers by Felix Gundling Breakdown of academic impact, for papers by Jason Soden
Rankless by CCL
2026